Bach Paul David 4
4 · Genesis Healthcare, Inc. · Filed Jun 4, 2020
Insider Transaction Report
Form 4
Transactions
- Award
Class A Common Stock
2020-06-02+205,000→ 839,615 total - Sale
Class A Common Stock
2020-06-03$0.95/sh−7,457$7,121→ 832,158 total
Footnotes (3)
- [F1]Grant of restricted stock units under the Issuer's 2015 Omnibus Equity Incentive Plan.
- [F2]Includes 499,349 unvested restricted stock units that have not yet been paid in shares of the Issuer's Class A Common Stock.
- [F3]The sales reported in this Form 4 were effected to satisfy the reporting person's income tax obligations with respect to the vesting of a restricted stock unit award.